Lyomark Pharma and InfectoPharm sign exclusive sales and distribution agreement for Alveofact® in Germany

OBERHACHING / HEPPENHEIM – 21 February 2020 – Lyomark Pharma GmbH, the German manufacturer of Alveofact®, and InfectoPharm Arzneimittel und Consilium GmbH, today announced that they have entered into an exclusive agreement for distribution of Alveofact® in Germany. Based on this agreement, InfectoPharm will be the exclusive distributor of Alveofact® on the German market. Specialising … Read more

Change in management – a change at the top of Lyomark Pharma GmbH

A change at the top of Lyomark Pharma GmbH: As of 1st April 2019, Christian Parvany (41) will join the management team of the company as Dr Helmut Wolf ends his tenure as managing director of Lyomark Pharma, a positionhe has held for more than 25 years. Dr Wolf will remain at the company as … Read more

NeoKay® – Vitamin-K1-prophylaxis by Lyomark Pharma

Lyomark Pharma is expanding its product portfolio with its own vitamin-K1-prophylaxis for the German market: NeoKay® 1 mg soft capsules. Newborn babies may have a deficiency of vitamin K1, which can result in rare but serious and even fatal bleeding. To prevent such bleeding, NeoKay® is used prophylactically. According to german guidelines phytomenadione (vitamin K1) … Read more

Avoidance of plastic waste

In today’s world, plastics are ubiquitous. Every day, we encounter masses of plastic in packaging which, if used only once, is very worrying. On 19 December 2018, the EU finally issued a ban prohibiting the future use of plastic plates, drinking straws and other single-use plastics. Lyomark Pharma has been quick to acknowledge this significant … Read more